View Cart  

Seroquel XR Formulation Patent Deemed Valid, Good Through 2017

A A
With the initial version of AstraZeneca’s antipsychotic Seroquel now victim to a host of generic rivals, the drugmaker can be confident the product’s extended-release version is likely safe for another five years.

To View This Article:

Login

Subscribe To Drug Industry Daily